medigraphic.com

2002, Número 3

<< Anterior Siguiente >>

Cir Cir 2002; 70 (3)


La investigación en la salud de la mujer en el siglo XXI

Chavarría-Olarte ME, Palomo-Piñón S, Danel I, Granados-Martínez J

Idioma: Español
Referencias bibliográficas: 60
Paginas: 194-199
Archivo PDF: 50.88 Kb.


RESUMEN

Para el siglo XXI la expectativa de vida en la mujer ha aumentado por arriba de los 70 años, su estilo de vida se ha modificado, haciéndose más activa física, intelectual y sexualmente y la influencia de los factores sociales, culturales y medioambientales en su salud también es distinta. Por lo tanto, las enfermedades que aparecen con mayor frecuencia y las que provocan mayor mortalidad también han cambiado. Entre los aspectos que requieren de énfasis en la investigación en salud femenina en este siglo están: las conductas de riesgo relacionadas con actividad sexual, adicciones, violencia y modificación del entorno familiar; estrategias para favorecer los comportamientos saludables en cada etapa de la vida, como son hábitos alimenticios, actividad física e higiene general; prevención de enfermedades crónicas; salud reproductiva, incluyendo anticoncepción, salud durante el embarazo y la prevención, diagnóstico y tratamiento de enfermedades de transmisión sexual; influencia de factores genéticos, infecciosos, moleculares, hormonales y ambientales en las enfermedades; salud mental y enfermedades neurodegenerativas; la salud de la mujer climatérica. En la actualidad se hace un énfasis especial en la prevención del daño para mantener una vida saludable y en el desarrollo de indicadores moleculares con valor predictivo para la aparición y desarrollo de enfermedades cardiovasculares, mentales y crónico-degenerativas. Finalmente, la investigación social en medicina deberá analizar que tipo de intervenciones médicas, conductuales y sociales funcionan, con quién y por qué, para prevenir y tratar las enfermedades, así como para inducir a las mujeres a hacerse responsables de su salud.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Goldman MB, Hatch MC, editors. Women and health. New York: Academic Press; 2000.

  2. Day JC. Population projections of the United States by age, sex, race, and Hispanic origin: 1995-2050. Washington D.C., USA: Bureau of the Census. Current Population Reports; 1996.pp.25-1130.

  3. Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. J Fam Pract 2000;49:147-152.

  4. Giijsbers van Wijk CMT, Kolk AM van den Bosch WJHM, wan den Hoogen HJM. Male and female morbidity in general practice the nature of sex differences. Soc Sci Med 1992;35:665-678.

  5. Kenney JW, Bhattacharjee A. Interactive model of women’s stressors, personality traits and health problems. J Adv Nurs 2000; 32:249-258.

  6. Barnett RC, Marshal NL. The relationship between women’s work and family roles, and their subjective well-being and psychological distress. In: Frankenheuser M, Lundberg U, Chesney M, editors. Woman, Work, and Health: Streess and Opportunities. New York: Plenum Press; 1991.

  7. Hibbard JH, Pope CR. The quality of social roles as predictors of morbidity and mortality. Soc Sci Med 1993;36:217-225.

  8. Gesensway D. Reasons for sex-specific and gender-specific studies of health topics. Ann Intern Med 2001;135:935-938.

  9. Ayanian JZ, Epstein AM. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med 1991;325:221-225.

  10. Giles WH, Anda RF, Casper ML, Escobedo LG, Taylor HA. Race and sex differences in rates of invasive cardiac procedures in US hospitals: data from the National Hospital Discharge Survey. Arch Intern Med 1995;155:318-324.

  11. Mendelssohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-1811.

  12. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial: the Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimes on heart disease risk factors in postmenopausal women. JAMA 1995;273:199-208.

  13. Hanania NA, Chapman KR, Sturtridge WC, et al. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 1995;96:571-579.

  14. Ip M, Lam K, Yam L, et al. Decreased bone mineral density in premenopausal asthma patients receiving long-term inhalated steroids. Chest 1994;105:1722-1727.

  15. Chalk R, King PA. Violence in families: assessing prevention and treatment programs. In: Chalk R, King PA, editors. Health care interventions. Washington D.C., USA: National Academy Press; 1998..223-224.

  16. Williams JBW, Spitzer RL, Linzer M, Kroenke K, Hahn SR, et al. Gender differences in depression in primary care. Am J Obstet Gynecol 1995;173:654-659.

  17. Developmental biology. Understanding normal and abdominal development. NICHD Report 2001. http://www.nichd.nih.gov/publications/

  18. Genetics and fetal antecedents of disease susceptibility. NICHD Report 2001. http://www.nichd.nih.gov/publications/

  19. America’s children: key national Indicators of well-being. NICHD Report 2001. http://childstats.gov/

  20. Zametkin AJ, Alter MR, Yemini T. Suicide in teenagers: assessment, management, and prevention. JAMA 2001;286:3120-3125.

  21. Endocrinology, nutrition, and growth branch: Report to the NACHHD Council. September 2000. http://www.nichd.nih.gov/publications/

  22. Division of Epidemiology, Statistics, and Prevention Research: Report to the NACHHD Council. June 2001. http://www.nichd.nih.gov/publications/

  23. Contraception and reproductive health branch: Report to the NACHHD Council. September 1999. http://www.nichd.nih.gov/publications/

  24. Pregnancy and perinatology branch: Report to the NACHHD Council. January 2000. http://www.nichd.nih.gov/publications/

  25. Ness RB, Kuller LH. Health and disease among women: biological and environmental influences. Oxford, UK: Oxford University Press; 2000.

  26. Sword W. A socio-ecological approach to understanding barriers to prenatal care for women of low income. J Adv Nurs. 1999;29:1170-1177.

  27. Bauer GR, Welles SL. Beyond assumptions of negligible risk: sexually transmitted diseases and women who have sex with women. Am J Public Health 2001;91:1282-1286.

  28. Kiecolt-Glaser JK, Glaser R. Psychological influences on immunity: implications for AIDS. Am Psychol 1988;43:892-898.

  29. Kroenke K, Spitzer RL. Gender differences in the reporting of physical and somatoform symptoms. Psychosom Med 1998;60:150-155.

  30. Linzer M, Spitzer R, Kroenke K, et al. Gender, quality of life and mental disorders in primary care: results from the PRIME-MD 1000 study. Am J Med 1996;101:526-533.

  31. McCauley J, Kern DE, Kolodner K, et al. The “battering syndrome”: prevalence and clinical characteristics of domestic violence in primary care internal medicine practices. Ann Intern Med 1995;123:737-746.

  32. Drossman DA, Talley MJ, Leserman J, et al. Sexual and physical abuse in gastrointestinal illness: review and recommendations. Ann Int Med 1995;123:782-794.

  33. Feuer EJ, Wun LM, Boring CC. Probability of developing cancer. In: Miller BA, Ries LAG, Hankey BF, Kosary CL, SEER cancer statistics review: 1973-89. Vol. 30. Edwards BK, editors. Bathesda, MD, USA: National Cancer Institute; 1992.pp.1-13. NIH publications 92-2789.

  34. Fox SA, Roetzheim RG, Kington RS. Barriers to cancer prevention in the older person. In: Balducci L, Lyman GH, Ershler WB, editors. Comprehensive geriatric oncology. Philadelphia, PA, USA: JB Lippincott; 1997.pp.351-361.

  35. Roetzheim R, Fox SA, Leake B, Houn F. The National Cancer Institute Breast Cancer Screening Consortium. The influence of risk factors on breast carcinoma screening of Medicare-insured older women. Cancer 1996;78:2526-2534.

  36. Weiderpass E, Persson I, Melhus H, et al. Estrogen receptor alpha gene polymorphisms and endometrial cancer risk. Carcinogenesis 2000;21:623-627.

  37. Schuur ER, Weigel RJ. Monoallelic amplification of estrogen receptor-alpha expression in breast cancer. Cancer Res 2000;60:2598-2601.

  38. Georgiou I, Syrrou M, Bouba I, et al. Association of estrogen receptor gene polymorphisms with endometriosis. Fertil Steril 1999;n 72:164-166.

  39. Ji Y, Urakami K, Wada-isoe K, et al. Estrogen receptor gene polymorphisms in patients with Alzheimer’s disease, vascular dementia, and alcohol-associated dementia. Dement Geriatr Cong Disord 2000;11:119-122.

  40. Isoe-Wada K, Maeda M, Yong J, et al. Positive association between an estrogen receptor gene polymorphism and Parkinson’s disease with dementia. Eur J Neurol 1999;6:431-435.

  41. Hunt L. Women’s health: mental health needs. Nurs Manage (London) 1998;5:18-20.

  42. Shah N, Evans WS, Bowers CY, Veldhuis JD. Oral stradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women. J Clin Endocrinol Metab 2000;85:2649-2659.

  43. Gijsbers van Wijk CMT, van Vliet KP, Kolk AM, et al. Symptom sensitivity and sex differences in physical morbidity: a review of health surveys in the US and the Netherlands. Women Health 1991;17:91-124.

  44. Mosca L, Collins P, Herrington D, Mendelsohn ME, Pasternak RC, et al. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 2001;104:499-503.

  45. Butler RN. Sounding board on behalf of older women: another reason to protect Medicare and Medicaid. N Engl J Med 1996;334:794-796.

  46. Mosca L, Jones WK, King KB, et al. Awareness, perception and knowledge of heart disease risk and prevention among women in the United States: American Heart Association Women’s Heart Disease and Stroke Campaign Task Force. Arch Fam Med 2000;9:506-515.

  47. Giguere Y, Rousseau F. The genetics of osteoporosis: complexities and difficulties. Clin Genet 2000;57:161-169.

  48. Callahan D, ter Meulen RHJ, Topinkova E. A world growing old: the coming health care challenges. Washington, D.C., USA: Georgetown University Press; 1995.

  49. Ebrahim S, Kalach A. Epidemiology in old age. London: BMJ Publishing Group; 1996.

  50. Butler RM. Population againg and health. BMJ 1997;315:1082-1084.

  51. Merzel C. Gender differences in health care access indicators in an urban, low-income community. Am J Public Health 2000;90: 909-916.

  52. Subramanian G, Adams MD, Venter JC, Broder S. Implications of the human genome for understanding human biology and medicine. JAMA 2001;286:2296-2307.

  53. Collins FS, McKusick VA. Implications of the human genome project for medical science. JAMA 2001;285:540-544.

  54. Schimpf MO, Domino SE. Implications of the human genome project for obstetrics and gynecology. Obstet Gynecol Surv 2001;56:437-443.

  55. McKusick VA. The anatomy of the human genome: a neo-Vesalian basis for medicine in the 21st century. JAMA 2001;286:2289-2295.

  56. Van Dyke DC, Ellingrod VL, Berg MJ, et al. Pharmacogenetic screening for susceptibility to fetal malformations in women. Ann Pharmacother 2000;34:639-645.

  57. Thompson L. Correcting the code: inventing the genetic cure for the human body. New York: Simon & Schuster; 1994.

  58. Murphy TF, Lappe MA. Justice and the human genome project. Berkeley CA, USA: University of California Press; 1994.

  59. Jeffords JM, Daschle T. Political issues in the genome era. Science 2001;291:1249-1251.

  60. Vastag B. Experts wrestle with social, ethical implications of human genome research. JAMA 2001;285:721-722.




2020     |     www.medigraphic.com